Contributor
Nature Comms
Towards more affordable pneumococcal vaccines
Check out how we are developing an alternative, streamlined method for manufacturing pneumococcal conjugate vaccines all within the lab safe, bacterium E. coli…
Share the real story behind your paper, from conception to publication, the highs and the lows.